Affiliation:
1. Universiti Sains Malaysia
Abstract
Abstract
Background
Recent years have witnessed major development of novel therapeutic agents like chemotherapy, targeted therapy and immune checkpoint inhibitors for cervical cancer. However, cervical cancer remains prevalent, leading to a large number of deaths worldwide. A better understanding of the cervical cancer biology and signaling pathways might lead to the development of targeted therapies in reducing the incidence and mortality rate.
Methods
In this study, the RNA-Seq reads of HeLa cells treated with C. nutans were compared to the untreated sample. The reads of these two sample groups were firstly aligned to the human reference genome. The results in BAM files format that were generated were then sorted before being assembled. The output of assembly which was in coverage table form was ready for downstream statistical analyses for differential expression. Differentially expressed genes were obtained and the cell-death related pathway were identified by canonical pathway, QIAGEN Ingenuity Pathway Analysis (IPA). The verification of significant genes was carried out using qRT-PCR by including GAPDH as a housekeeping gene
Results
With this, we identified a total of 668 upregulated and 479 downregulated analysis-ready genes across observations upon cut-off setting log2FoldChange at 0.5 and P-value 0.05. A total of 28 cell-death related canonical pathways and 4 activation of cell-death related functions were identified. Upon analyses, we identified four significant genes (Casp9, KAI1, REL and FOXO4) that hold important role in promoting cell death. These findings were also verified against the quantification using qRT-PCR by including GAPDH as a housekeeping gene.
Conclusions
This study provides an insight on the potential role of DCM fraction of C. nutans in activating Casp9, KAI1, REL and FOXO4 genes in mediating apoptosis in cervical cancer cells.
Publisher
Research Square Platform LLC
Reference58 articles.
1. He Z, Wang X, Yang Z, Jiang Y, Li L, Wang X, et al. Expression and prognosis of CDC45 in cervical cancer based on the GEO database. PeerJ. 2021;9(Cc).
2. Fuzzell LN, Perkins RB, Christy SM, Lake PW, Vadaparampil ST. Cervical cancer screening in the United States: Challenges and potential solutions for underscreened groups. Prev Med (Baltim) [Internet]. 2021;144(January):106400. Available from: https://doi.org/10.1016/j.ypmed.2020.106400
3. Cervical cancer immunotherapy: Facts and hopes;Ferrall L;Clin Cancer Res,2021
4. The Potential of Chinese Herbal Medicines in the Treatment of Cervical Cancer;Hsiao YH;Integr Cancer Ther,2019
5. Transcriptome analysis reveals the potential biological function of FSCN1 in HeLa cervical cancer cells;Guo F;PeerJ,2022